NLRP3 and cryopyrin-associated periodic syndrome: A more recent paper on the rare disease cryopyrin-associated periodic syndromes (CAPS, caused by NLRP3 mutations and consequent overproduction of IL-1β) suggested that MDSCs might act in an anti-inflammatory manner and exert beneficial effects (53).